Patient Guide: A Clinical Study of V940 and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 34 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06961006
Status: 🟢 Enrolling Now
Condition: Malignant Melanoma
Phase: PHASE2

Where You Can Participate

This study is available at 34 locations across the country.

Top locations include:
  • • Springdale, Arkansas
  • • San Francisco, California
  • • Hackensack, New Jersey
  • • And 31 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Clinical Study of V940 and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012) - Join Clinical Trial NCTNCT06961006

How to Join This Clinical Trial - NCTNCT06961006

Learn how to participate in this PHASE2 trial studying an investigational therapy for Malignant Melanoma. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Malignant Melanoma. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Malignant Melanoma
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06961006 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 34 locations. Find a study site near you:

Clinical Research Site

Springdale, Arkansas 72762 - United States

Status: RECRUITING

Clinical Research Site

San Francisco, California 94158 - United States

Status: RECRUITING

Clinical Research Site

Hackensack, New Jersey 07601 - United States

Status: RECRUITING

Clinical Research Site

Fairfax, Virginia 22031 - United States

Status: RECRUITING

Clinical Research Site

Seattle, Washington 98109 - United States

Status: RECRUITING

Clinical Research Site

Blacktown, New South Wales 2148 - Australia

Status: RECRUITING

Clinical Research Site

Wollstonecraft, New South Wales 2065 - Australia

Status: RECRUITING

Clinical Research Site

Nedlands, Western Australia 6009 - Australia

Status: RECRUITING

Clinical Research Site

Nice, Alpes-Maritimes 06202 - France

Status: RECRUITING

Clinical Research Site

Paris, Île-de-France Region 75010 - France

Status: RECRUITING

And 24 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Malignant Melanoma:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships